Drugs Made In America Acquisition Corp. Ordinary Shares

DMAANASDAQ • USD
10.84 USD
↘ 0.01 (0.09%)AT CLOSE (11:59 AM EDT)
10.83
↘ 0.01 (0.05%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
10.83
↘ 0.01 (0.05%)
🔴Market: CLOSED

Shares of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) are trading at $10.85. DMAA shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Sep 25, 2026.

Open?$10.83
High?$10.84
Low?$10.83
Prev. Close?$10.85
Volume?1.5K
Avg. Volume?33.5K
VWAP?$10.83
Rel. Volume?0.04x
Bid / Ask
Bid?$9.28 × 100
Ask?$14.97 × 100
Spread?$5.69
Midpoint?$12.13
Valuation & Ratios
Market Cap?263.4M
Shares Out?24.3M
Float?21.0M
Float %?86.7%
P/E Ratio?32.24
P/B Ratio?-35.57
EPS?$0.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Drugs Made In America Acquisition Corp is a blank check company.
Employees
N/A
Market Cap
263.4M
Industry
BLANK CHECKS
Website
N/A
Listed
2025-02-25
Address
420 LEXINGTON AVENUE
NEW YORK, NY 10170
Phone: 646-726-7074
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
50
Momentum?
50
Short Sent.?
60
Piotroski F-Score?0/9Weak
Confidence?50%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.44%Low
Short Interest?92.5K
Days to Cover?1.3
Free Float21.0M
Avg Daily Volume70.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?0.02Weak
Quick Ratio?0.02Weak
Cash Ratio?0.01Low
Debt/Equity?-0.05Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
78/100
P/E?
Peers
100
S&P
28
32.2PRICEY▾
P/B?
S&P
97
-35.57CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-390.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-110.3%WEAK▾
ROA?
Peers
50
S&P
50
5.6%FAIR▾
Cash Flow & Enterprise
FCF?$-498620
Enterprise Value?$263.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist